ArticleAmerican journal of hematology2019
A final note about ibrutinib in relapsed or refractory CLL: Conclusive results from RESONATE sound definitely good!
Michele Merli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it